Inverse horse-shoe technique for the phacoemulsification of posterior polar cataract.
OBJECTIVE
To study a new technique of controlled hydrodelineation followed by viscodelineation and viscodissection during phacoemulsification in eyes with posterior polar cataracts and to report its effectiveness in preserving the posterior capsule.


METHODS
Prospective interventional study.


METHODS
Twenty-eight eyes of 22 patients with posterior polar cataracts.


METHODS
All patients underwent phacoemulsification under topical anaesthesia with controlled hydrodelineation, viscodelineation, and viscodissection with minimal stress on the posterior capsule. Hydrodissection was not done. The preoperative complications and visual outcome were recorded.


RESULTS
The mean follow-up time was 8 months (range 2-24 months). Posterior capsule rupture occurred only in 2 eyes (7.1%); neither of the 2 had any vitreous prolapse, so anterior vitrectomy was not required. Mean visual acuity improved significantly after surgery (p = 0.0001, paired t test). The causes of the low postoperative visual acuity were amblyopia in 3 eyes (10.7%) and age-related macular degeneration in 1 (3.6%).


CONCLUSIONS
This inverse horse-shoe technique of controlled viscodelineation and viscodissection markedly reduced the risk of posterior capsule rupture. Moreover, if it occurred, the anterior vitreous face remained intact, so the IOL could be implanted in the sulcus without resorting to anterior vitrectomy.
Salahuddin
Ahmad
A
Eye Department, Combined Military Hospital, Rawalpindi, Pakistan. muzains7@hotmail.com
D000328:Adult; D000368:Aged; D002386:Cataract / Q000145:classification*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007431:Intraoperative Complications; D007903:Lens Capsule, Crystalline / Q000293:injuries; D019654:Lens Implantation, Intraocular; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification / Q000379:methods*; D011446:Prospective Studies; D019591:Pseudophakia / Q000503:physiopathology; D012421:Rupture / Q000517:prevention & control; D016896:Treatment Outcome; D055682:Viscoelastic Substances / Q000008:administration & dosage; D014792:Visual Acuity / Q000502:physiology
D055682:Viscoelastic Substances